Summary of Omnicell, Inc. (NASDAQ:OMCL) Ratings on Jun 27, 2018

June 27, 2018 - By Samuel McNeil

Omnicell, Inc. (NASDAQ:OMCL) Corporate Logo
Big Money Sentiment decreased to 1.03 in Q1 2018. It has change of 0.09, from 2017Q4’s 1.12. The ratio is negative due to Omnicell, Inc. positioning: 26 sold and 69 reduced. 30 funds amassed positions and 68 increased positions. Investors holded 37.38 million in 2017Q4 but now own 37.13 million shares or 0.68% less.
Teacher Retirement Systems Of Texas invested in 0% or 8,395 shs. Credit Suisse Ag, a Switzerland-based fund reported 35,903 shs. Comerica Fincl Bank reported 0.03% stake. Champlain Invest Ptnrs Ltd has invested 0.71% of its capital in Omnicell, Inc. (NASDAQ:OMCL). King Luther Cap Management owns 75,315 shs or 0.03% of their US capital. Moreover, Martingale Asset L P has 0.02% invested in Omnicell, Inc. (NASDAQ:OMCL). State Street has 957,268 shs for 0% of their capital. Moreover, Torray Limited Liability Corp has 0.1% invested in Omnicell, Inc. (NASDAQ:OMCL). Paloma Ptnrs Mngmt Company has 0% invested in Omnicell, Inc. (NASDAQ:OMCL). Wellington Group Inc Llp invested in 690,724 shs. Ls Advsr accumulated 3,436 shs. Waddell Reed Fincl Inc invested 0.01% of its capital in Omnicell, Inc. (NASDAQ:OMCL). Tiaa Cref Mngmt Lc has invested 0% of its capital in Omnicell, Inc. (NASDAQ:OMCL). Secor Advsr L P owns 6,553 shs. 208,312 are held by Snyder Capital L P.

Omnicell, Inc. had 12 selling transactions and 0 insider purchases since March 6, 2018. This’s net activity of $5.06 million. $751,584 worth of Omnicell, Inc. (NASDAQ:OMCL) was sold by Seim Robin Gene. DREW J CHRISTOPHER sold $471,778 worth of stock or 9,401 shs. 11,284 Omnicell, Inc. (NASDAQ:OMCL) shs with value of $507,248 were sold by JOHNSTON DAN S. Kuipers Peter J. sold 3,456 shs worth $164,562. $213,946 worth of Omnicell, Inc. (NASDAQ:OMCL) was sold by Ngo Nhat H on Tuesday, June 19. On Thursday, March 15 PETERSMEYER GARY S sold $25,544 worth of Omnicell, Inc. (NASDAQ:OMCL) or 575 shs.

Omnicell, Inc. (NASDAQ:OMCL) Ratings Coverage

Total analysts of 4 have positions in Omnicell (NASDAQ:OMCL) as follows: 2 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 50%. Since January 29, 2018 according to StockzIntelligence Inc Omnicell has 5 analyst reports. On Friday, February 2 the company was downgraded by Craig Hallum. On Thursday, April 26 the stock has “Buy” rating by Cantor Fitzgerald. On Thursday, February 1 the firm has “Buy” rating by Cantor Fitzgerald given. On Monday, January 29 the stock of Omnicell, Inc. (NASDAQ:OMCL) has “Buy” rating given by Oppenheimer. On Friday, February 2 PiperJaffray maintained the shares of OMCL in report with “Neutral” rating. Listed here are Omnicell, Inc. (NASDAQ:OMCL) PTs and latest ratings.

26/04/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $63.0000 Maintain
02/02/2018 Broker: PiperJaffray Old Rating: Neutral New Rating: Neutral Old Target: $38 New Target: $44 Maintain
02/02/2018 Broker: Craig Hallum Rating: Hold Downgrade
01/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $63.0 Maintain
29/01/2018 Broker: Oppenheimer Rating: Buy New Target: $55.0 Maintain

Ticker’s shares touched $52.6 during the last trading session after 0.57% change.Omnicell, Inc. has volume of 35,039 shares. Since June 27, 2017 OMCL has risen 10.62% and is uptrending. The stock underperformed the S&P 500 by 1.95%.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide.The firm is worth $2.05 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence.The P/E ratio is 61.66. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

Another two news for Omnicell, Inc. (NASDAQ:OMCL) were briefly posted by: Themiddlemarket.com on June 20, 2018 with title “Robotics developers are ripe for investment, says Innovation Works CEO Rich Lunak”. The other Prnewswire.com‘s article was titled “STOMPP Study Demonstrates Multimed Packaging Improves Medication Adherence” and posted on June 12, 2018.

Omnicell, Inc. (NASDAQ:OMCL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: